Sökning: id:"swepub:oai:DiVA.org:liu-99822" >
Inflammation and an...
Inflammation and anaemia in a broad spectrum of patients with heart failure
-
- Kleijn, Lennaert (författare)
- University Medical Center Groningen, Netherlands
-
- Belonje, Anne M S (författare)
- University Medical Center Groningen, Netherlands
-
- Voors, Adriaan A (författare)
- University Medical Center Groningen, Netherlands
-
visa fler...
-
- De Boer, Rudolf A (författare)
- University Medical Center Groningen, Netherlands
-
- Jaarsma, Tiny (författare)
- Linköpings universitet,Hälsa, Aktivitet, Vård (HAV),Hälsouniversitetet,University Medical Center Groningen, Netherlands
-
- Ghosh, Sudip (författare)
- Amgen Ltd, Cambridge, UK
-
- Kim, Joseph (författare)
- Amgen Ltd, Cambridge, UK
-
- Hillege, Hans L (författare)
- University Medical Center Groningen, Netherlands
-
- Van Gilst, Wiek H (författare)
- University Medical Center Groningen, Netherlands
-
- van Veldhuisen, Dirk J (författare)
- University Medical Center Groningen, Netherlands
-
- van der Meer, Peter (författare)
- University Medical Center Groningen, Netherlands
-
visa färre...
-
(creator_code:org_t)
- 2012-06-22
- 2012
- Engelska.
-
Ingår i: Heart. - : BMJ Publishing Group. - 1355-6037 .- 1468-201X. ; 98:16, s. 1237-1241
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- AIMS: Anaemia in heart failure (HF) is associated with a poor prognosis. Although inflammation is assumed to be an important cause of anaemia, the association between anaemia and inflammatory markers in patients with HF has not been well established.METHODS: Data from a multicentre randomised clinical trial, in which patients were eligible if they were >18 years of age and admitted for HF (New York Heart Association II-IV), were used. In a subset of 326 patients, haemoglobin (Hb), haematocrit, high sensitivity C-reactive protein (hsCRP), interleukin-(IL) 6, soluble tumour necrosis factor receptor (sTNFR)-1 and erythropoietin (Epo) were measured at discharge and the primary endpoint was all-cause mortality. Follow-up was 18 months.RESULTS: Anaemia (Hb <13 g/dl (men) and <12 g/dl (women)) was present in 40% (130/326) of the study population. Median levels of IL-6, hsCRP and sTNFR-1 were significantly higher in anaemic patients than in non-anaemic patients. Logistic regression demonstrated that each increase in hsCRP values (OR 1.58 per SD log hsCRP; 95% CI 1.09 to 2.29; p=0.016) and each increase in sTNFR-1 values (OR 1.62 per SD log sTNFR-1; 95% CI 1.24 to 2.11; p<0.001) were independently associated with anaemia. Epo (HR 1.31 per log Epo; 95% CI 1.01 to 1.69; p=0.041) and sTNFR-1 (HR 1.47 per log sTNFR-1; 95% CI 1.16 to 1.86; p=0.001) levels were independently associated with outcome.CONCLUSION: Anaemia is present in 40% of patients hospitalised for HF and is independently associated with inflammation.
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
Heart
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Kleijn, Lennaert
-
Belonje, Anne M ...
-
Voors, Adriaan A
-
De Boer, Rudolf ...
-
Jaarsma, Tiny
-
Ghosh, Sudip
-
visa fler...
-
Kim, Joseph
-
Hillege, Hans L
-
Van Gilst, Wiek ...
-
van Veldhuisen, ...
-
van der Meer, Pe ...
-
visa färre...
- Artiklar i publikationen
-
Heart
- Av lärosätet
-
Linköpings universitet